186 related articles for article (PubMed ID: 12567186)
1. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.
Hemann MT; Fridman JS; Zilfou JT; Hernando E; Paddison PJ; Cordon-Cardo C; Hannon GJ; Lowe SW
Nat Genet; 2003 Mar; 33(3):396-400. PubMed ID: 12567186
[TBL] [Abstract][Full Text] [Related]
2. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model.
Bric A; Miething C; Bialucha CU; Scuoppo C; Zender L; Krasnitz A; Xuan Z; Zuber J; Wigler M; Hicks J; McCombie RW; Hemann MT; Hannon GJ; Powers S; Lowe SW
Cancer Cell; 2009 Oct; 16(4):324-35. PubMed ID: 19800577
[TBL] [Abstract][Full Text] [Related]
3. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
4. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis.
Hsu B; Marin MC; el-Naggar AK; Stephens LC; Brisbay S; McDonnell TJ
Oncogene; 1995 Jul; 11(1):175-9. PubMed ID: 7624125
[TBL] [Abstract][Full Text] [Related]
5. Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene.
Tatemichi M; Tazawa H; Masuda M; Saleem M; Wada S; Donehower LA; Ohgaki H; Ohshima H
Int J Cancer; 2004 Oct; 111(6):819-28. PubMed ID: 15300793
[TBL] [Abstract][Full Text] [Related]
6. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model.
Scherr M; Battmer K; Dallmann I; Ganser A; Eder M
Oligonucleotides; 2003; 13(5):353-63. PubMed ID: 15000826
[TBL] [Abstract][Full Text] [Related]
8. Biology of marrow stromal cell lines derived from long-term bone marrow cultures of Trp53-deficient mice.
Epperly MW; Bray JA; Carlos TM; Prochownik E; Greenberger JS
Radiat Res; 1999 Jul; 152(1):29-40. PubMed ID: 10381838
[TBL] [Abstract][Full Text] [Related]
9. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
10. Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice.
Yue Y; Leung SG; Liu Y; Huang Y; Grundt K; Østvold AC; Jen KY; Schild D; Mao JH; Wiese C
Oncotarget; 2016 Sep; 7(38):61874-61889. PubMed ID: 27542204
[TBL] [Abstract][Full Text] [Related]
11. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
12. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.
Amaravadi RK; Yu D; Lum JJ; Bui T; Christophorou MA; Evan GI; Thomas-Tikhonenko A; Thompson CB
J Clin Invest; 2007 Feb; 117(2):326-36. PubMed ID: 17235397
[TBL] [Abstract][Full Text] [Related]
13. Constitutive and conditional RNAi transgenesis in mice.
Kleinhammer A; Wurst W; Kühn R
Methods; 2011 Apr; 53(4):430-6. PubMed ID: 21184828
[TBL] [Abstract][Full Text] [Related]
14. Small RNA: can RNA interference be exploited for therapy?
Wall NR; Shi Y
Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: strain differences in bone marrow tissue responses observed using microarrays.
Inoue T; Hirabayashi Y
Chem Biol Interact; 2010 Mar; 184(1-2):240-5. PubMed ID: 20018183
[TBL] [Abstract][Full Text] [Related]
16. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
18. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
19. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
Yu D; Thomas-Tikhonenko A
Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
[TBL] [Abstract][Full Text] [Related]
20. Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development.
Aubrey BJ; Janic A; Chen Y; Chang C; Lieschke EC; Diepstraten ST; Kueh AJ; Bernardini JP; Dewson G; O'Reilly LA; Whitehead L; Voss AK; Smyth GK; Strasser A; Kelly GL
Genes Dev; 2018 Nov; 32(21-22):1420-1429. PubMed ID: 30366906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
